Iron preparation given in anemia in pregnancy 10 mark answer

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Excellent content! I have very rich information. Let me now compile the comprehensive 10-mark answer.

Iron Preparations in Anemia in Pregnancy

Introduction

Anemia is the most common medical complication of pregnancy, defined by the WHO as hemoglobin (Hb) < 11 g/dL in the first and third trimesters, and < 10.5 g/dL in the second trimester. Iron deficiency is responsible for approximately 75% of all anemias in pregnancy, with a prevalence as high as 47%. Treatment with the appropriate iron preparation is the cornerstone of management.
(Creasy & Resnik's Maternal-Fetal Medicine)

Why Iron Requirements Increase in Pregnancy

During pregnancy, the total iron requirement increases substantially:
  • 300 mg for the fetus and placenta
  • 500 mg for expansion of maternal red cell mass
  • 200 mg for basal losses
  • Total: ~1000 mg (approximately 6-7 mg/day, well above the usual dietary intake of 1-2 mg/day absorbed)

Classification of Iron Preparations

A. Oral Iron Preparations

Oral iron is the first-line treatment for iron deficiency anemia (IDA) in pregnancy.

1. Ferrous Sulphate (Most commonly used)

  • Dose: 325 mg (containing 65 mg elemental iron) one to three times daily
  • The WHO recommends 60 mg elemental iron daily combined with folic acid for all pregnant women
  • 30 mg may be sufficient when combined with other micronutrients
  • Mechanism: Ferrous (Fe²+) form is better absorbed in the duodenum and upper jejunum via DMT-1 (divalent metal transporter-1)
  • Reticulocytosis expected in 7-10 days; Hb should rise ~1 g/dL per week
  • Treatment should continue for 3-6 months postpartum to replenish iron stores

2. Ferrous Gluconate

  • Contains 35 mg elemental iron per 325 mg tablet
  • Better tolerated gastrointestinally than ferrous sulphate
  • Used when GI side effects of ferrous sulphate are intolerable

3. Ferrous Fumarate

  • Contains 106 mg elemental iron per 325 mg tablet
  • Higher elemental iron content per tablet
  • Also well tolerated

4. Ferric (Fe³+) Preparations

  • Less well absorbed than ferrous preparations
  • Require reduction to Fe²+ before absorption
  • Examples: ferric ammonium citrate, ferric hydroxide polymaltose (Maltofer)
  • Fewer GI side effects but lower bioavailability
Important note: Other oral iron preparations are more expensive and offer no advantage over ferrous sulphate if equal amounts of elemental iron are given.

Oral Iron - Practical Tips

  • Best absorbed on an empty stomach (take 30 minutes before meals)
  • Vitamin C (ascorbic acid) enhances absorption
  • Avoid concurrent intake with calcium, antacids, tea, coffee, or cereals (reduce absorption)
  • A single daily dose is as effective as multiple-dose regimens and reduces GI side effects (important as GERD is already heightened in pregnancy)
  • Common side effects: nausea, constipation, black stools, epigastric discomfort

B. Parenteral Iron Preparations

Parenteral iron is indicated when:
  1. Patient cannot tolerate oral iron
  2. Non-compliance or poor oral absorption (e.g., inflammatory bowel disease, bariatric surgery)
  3. Severe anemia requiring rapid correction (especially in third trimester)
  4. Need to rapidly replenish iron stores before surgery or delivery
  5. Anemia unresponsive to oral therapy
Because iron demands in pregnancy are highest after 20 weeks' gestation, parenteral iron is most relevant in the second and third trimesters.

1. Iron Sucrose (Venofer) - Preferred IV preparation

  • Administered intravenously (IV)
  • Pregnancy category B (generally considered safe)
  • 200 mg in 100 mL normal saline over 15-30 minutes
  • Total dose calculated by Ganzoni formula:
    Total iron deficit (mg) = Weight (kg) × (Target Hb - Actual Hb) × 0.24 + 500
  • Requires multiple sessions (given in divided doses of 100-200 mg)
  • Very low risk of anaphylaxis; test dose usually not required

2. Ferric Gluconate (Sodium Ferric Gluconate)

  • IV preparation, pregnancy category B
  • 125 mg in 100 mL normal saline over 1 hour
  • Also requires multiple infusions
  • Good safety profile in pregnancy

3. Ferric Carboxymaltose (Ferinject)

  • Can deliver a large single dose (up to 1000 mg)
  • Fewer infusion visits needed
  • Lower risk of infusion reactions
  • Increasing use in obstetric practice

4. Low Molecular Weight (LMW) Iron Dextran

  • Pregnancy category C - used with caution
  • Higher risk of anaphylaxis than iron sucrose or gluconate
  • Advantage: can deliver the entire calculated dose in a single session
  • Test dose mandatory before full infusion
  • Rarely first choice in modern practice

5. Iron Dextran (High Molecular Weight) - Historical

  • Largely abandoned due to high rate of severe anaphylactic reactions
  • Not recommended in current practice
Parenteral iron side effects: Anaphylaxis/infusion reactions (especially dextran), headache, myalgia, flushing, hypotension, transient hypophosphatemia (ferric carboxymaltose).

C. Intramuscular (IM) Iron - Imferon / Iron Sorbitol

  • Iron sorbitol citric acid complex (Jectofer)
  • Given IM deep into the gluteal muscle using Z-track technique to avoid staining
  • Largely obsolete - painful, unpredictable absorption, skin staining, high systemic toxicity risk
  • Should not be used if IV access is available
  • Z-track injection technique mandatory to prevent permanent skin discoloration

Response to Iron Therapy - Monitoring

ParameterExpected Response
Reticulocytosis7-10 days
Hb rise~1 g/dL per week
Serum ferritin normalizationSeveral months
Duration of treatmentContinue 3 months after Hb correction
If there is no response after 3-4 weeks, consider:
  • Non-compliance
  • Incorrect diagnosis (not IDA - e.g., thalassemia)
  • Ongoing blood loss
  • Vitamin B6 deficiency (Vitamin B6 normally decreases in pregnancy; B6 + iron supplementation improves response)
  • Malabsorption

Role of Erythropoietin

Subcutaneous erythropoietin (EPO) with or without oral or parenteral iron has been used successfully to treat severe IDA in pregnancy, with no significant maternal risks. It is used primarily in:
  • Patients who refuse blood transfusion (e.g., Jehovah's Witnesses)
  • Chronic kidney disease complicating pregnancy
  • Severe refractory anemia
(Creasy & Resnik's Maternal-Fetal Medicine)

Blood Transfusion

Reserved for acute hemorrhage or severe symptomatic anemia (Hb < 7 g/dL) with cardiovascular compromise. Transfusion does not replenish iron stores and carries risks of alloimmunization, infections, and transfusion reactions. It is not a substitute for iron therapy.

Summary Table

PreparationRouteElemental IronPregnancy CategoryKey Feature
Ferrous sulphateOral65 mg/325 mgSafeFirst line
Ferrous gluconateOral35 mg/325 mgSafeBetter GI tolerance
Ferrous fumarateOral106 mg/325 mgSafeHigh elemental content
Iron sucroseIV100-200 mg/doseBSafest IV option
Ferric gluconateIV125 mg/doseBSafe IV alternative
Ferric carboxymaltoseIVUp to 1000 mgSafeHigh single dose
LMW Iron dextranIVFull dose calculableCTest dose needed
Iron sorbitolIMVariableObsoleteAvoid - skin staining

Conclusion

Oral ferrous sulphate remains the standard first-line treatment for iron deficiency anemia in pregnancy due to its efficacy, safety, and low cost. IV iron sucrose or ferric carboxymaltose are safe and effective alternatives when oral therapy fails or is contraindicated, particularly in the second and third trimesters when iron demand peaks. Adequate monitoring of response, continued treatment post-delivery, and dietary counseling are integral to comprehensive management.
(Sources: Creasy & Resnik's Maternal-Fetal Medicine; Harrison's Principles of Internal Medicine 22E; Harriet Lane Handbook 23e)
This is a shared conversation. Sign in to Orris to start your own chat.